Africa will get €10 million ($10.47 million) from the European Commission (EC) to develop a vaccine targeted at preventing placental malaria.
Placental malaria occurs when infected maternal red blood cells accumulate in the placental intervillous space, resulting in stillbirths, low birth weight, preterm birth or babies who are born smaller than usual.